Stopping Ulcerative Colitis Progression in its Tract

PROGRAM DESCRIPTION Managing patients with ulcerative colitis (UC) is as complex as the disease itself. As science progresses the understanding of UC, strategies for its management have also progressed. Treatment ...

PROGRAM DESCRIPTION
Managing patients with ulcerative colitis (UC) is as complex as the disease itself. As science progresses the understanding of UC, strategies for its management have also progressed. Treatment goals have now shifted from resolution of symptoms to full control of the disease (clinical remission and mucosal healing), with a final aim of halting or preventing disease progression, surgery, and disability; and restoration of quality of life. This enduring material provides clinicians with evidence-based direction to achieve sustained remission in UC through implementation of early intervention of treat-to-target approaches as recommended by the AGA UC Care Pathway. Dr. Rubin and Dr. Regueiro will integrate interactive infographics to provide a targeted review of the MOA of biologics and explain the impact of these biologics on histological and endoscopic disease progression for learners to explore. After the symposium these infographics can serve as an educational resource for use in practice to enhance patient health literacy about UC and to facilitate shared decision-making with patients.

EDUCATIONAL OBJECTIVES
At the end of this CME/CE activity, participants should be able to:Physicians/PAsExamine the rationale for the use of early, effective treatment in altering the progression course of ulcerative colitis (UC).Utilize the AGA Clinical Care Pathway to guide personalized biologic therapy to halt disease progression in UC.Incorporate disease activity monitoring strategies, including objective measures of disease improvement, to facilitate optimal management of UC.CNE/CPEExamine the rationale for the use of early, effective treatment in altering the progressive course of ulcerative colitis (UC).Explain the AGA UC Care Pathway to guide personalized biologic therapy to halt disease progression in UC.Describe disease activity monitoring strategies, including objective measures of disease improvement, to facilitate optimal management of UC.

---

Write the first review

Resource tags